← All Biovie INC filings

Biovie INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
BIVI
Biovie INC
DEF: BioVie Seeks Shareholder Approval for Equity Plan Expansion
BioVie Inc. will hold its 2025 Annual Meeting virtually to elect directors, ratify auditors, and approve a significant increase in shares for its equity incentive plan.
NASDAQ
BIVI
Biovie INC
DEF: BioVie Inc. Seeks Shareholder Approval for Reverse Stock Split to Maintain Nasdaq Listing and Boost Investor Appeal
BioVie Inc. has called a Special Meeting of Stockholders for June 23, 2025, to vote on a reverse stock split aimed at increasing its share price to maintain Nasdaq listing compliance and potentially attract institutional investors.
NASDAQ
BIVI
Biovie INC
DEFA14A: BioVie Inc. Updates Executive and Director Compensation in Proxy Statement Supplement
BioVie Inc. has released a supplement to its definitive proxy statement, updating disclosures related to executive and director compensation, outstanding equity awards, and related party transactions.
NASDAQ
BIVI
Biovie INC
DEF 14A: BioVie Inc. Seeks Stockholder Approval for Director Elections, Auditor Ratification, Executive Compensation, and Equity Incentive Plan Amendment
BioVie Inc. is convening its annual stockholder meeting on November 7, 2024, to vote on key proposals including the election of directors, ratification of the auditor, executive compensation, and an amendment to the equity incentive plan.
NASDAQ
BIVI
Biovie INC
DEF 14A: BioVie Inc. Seeks Stockholder Approval for Reverse Stock Split to Maintain Nasdaq Listing
BioVie Inc. is asking stockholders to approve a reverse stock split to maintain its Nasdaq listing and enhance the appeal of its common stock.